ORFV can carry TRAP gene expression via intracellular CRISPR/Cas9 gene editing technology

被引:2
作者
Yu, YongZhong [1 ]
Zhang, Fan [1 ]
Duan, Xuyang [1 ]
Yang, ChaoQun [1 ]
Cui, YuDong [1 ]
Yu, Li [2 ]
机构
[1] Heilongjiang Bayi Agr Univ, Coll Biol Sci & Technol, Daqing 163319, Peoples R China
[2] Chinese Acad Agr Sci, Harbin Vet Res Inst, Div Livestock Infect Dis, State Key Lab Vet Biotechnol, 427 Maduan St, Harbin 150001, Peoples R China
关键词
Orf virus; Staphylococcus aureus; TRAP; CRISPR; Cas9; technique; ORFV-TRAP recombinant virus; ENDOTHELIAL GROWTH-FACTOR; VIRUS-INFECTION; PARAPOXVIRUSES; IMMUNITY; GENOMES; PROTEIN; TARGET;
D O I
10.1016/j.jviromet.2022.114652
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Orf is an acute and highly contracted human and animal infection caused by orf virus (ORFV), which mainly affects sheep, goats, and other species. Clinically, opportunistic or conditional pathogens such as Staphylococcus aureus (S. aureus) are often detected in cases of orf, which greatly increases the risk of disease progression and clinical death. It has been reported that TRAP gene products of S. aureus can broadly influence bacterial life and pathogenicity in vivo, and introduction of exogenous TRAP genes may help to inhibit the proliferation of bacteria. In order to achieve the combined control of ORFV and S. aureus, a novel approach to design a S. aureus TRAP gene vaccine using a live attenuated ORFV vector is proposed. In this study, CRISPR/Cas9 gene editing technology was used to disable vascular endothelial growth factor E of ORFV (VEGF-v) and introduced TRAP gene into this position. TRAP gene expression was detected in keratinocytes infected with recombinant virus. The construction and experimental verification of recombinant ORFV (ORFV-v/TRAP) will provide a reference for indepth studies on the prevention and control of mixed infectious disease.
引用
收藏
页数:13
相关论文
共 50 条
[21]   Cas9 immunity creates challenges for CRISPR gene editing therapies [J].
Crudele, Julie M. ;
Chamberlain, Jeffrey S. .
NATURE COMMUNICATIONS, 2018, 9
[22]   CRISPR/Cas9 gene editing for curing sickle cell disease [J].
Park, So Hyun ;
Bao, Gang .
TRANSFUSION AND APHERESIS SCIENCE, 2021, 60 (01)
[23]   Crop gene editing against biotic stresses via CRISPR/Cas9 tools: a review [J].
Bashar, Kazi Khayrul ;
Abu Hanif, Md .
ARCHIVES OF PHYTOPATHOLOGY AND PLANT PROTECTION, 2021, 54 (15-16) :1159-1181
[24]   CRISPR/Cas9 and gene therapy [J].
Giono, Luciana E. .
MEDICINA-BUENOS AIRES, 2017, 77 (05) :405-409
[25]   Comparison of CRISPR/Cas9 and Cas12a for gene editing in Chlamydomonas reinhardtii [J].
Ferenczi, Aron ;
Fellbaum, Matthew ;
Chew, Yen Peng ;
Kidner, Catherine ;
Molnar, Attila .
ALGAL RESEARCH-BIOMASS BIOFUELS AND BIOPRODUCTS, 2024, 84
[26]   CRISPR/Cas9-mediated gene editing in human zygotes using Cas9 protein [J].
Tang, Lichun ;
Zeng, Yanting ;
Du, Hongzi ;
Gong, Mengmeng ;
Peng, Jin ;
Zhang, Buxi ;
Lei, Ming ;
Zhao, Fang ;
Wang, Weihua ;
Li, Xiaowei ;
Liu, Jianqiao .
MOLECULAR GENETICS AND GENOMICS, 2017, 292 (03) :525-533
[27]   Research progress and application of the CRISPR/Cas9 gene-editing technology based on hepatocellular carcinoma [J].
Yu, Shijing ;
Zhao, Ruirui ;
Zhang, Bingchen ;
Lai, Chunmei ;
Li, Linyan ;
Shen, Jiangwen ;
Tan, Xiarong ;
Shao, Jingwei .
ASIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2023, 18 (04)
[28]   CRISPR/Cas9 gene editing: A new hope for transthyretin amyloidosis treatment [J].
Shahzad, Faizan ;
Rehman, Mohammad Ebad Ur ;
Basit, Jawad ;
Saeed, Sajeel ;
Abbas, Khawar ;
Farhan, Muhammad .
ANNALS OF MEDICINE AND SURGERY, 2022, 83
[29]   Application of CRISPR/Cas9 technology in wild apple (Malus sieverii) for paired sites gene editing [J].
Zhang, Yan ;
Zhou, Ping ;
Bozorov, Tohir A. ;
Zhang, Daoyuan .
PLANT METHODS, 2021, 17 (01)
[30]   A Novel Anti-Cancer Therapy: CRISPR/Cas9 Gene Editing [J].
Chen, Xin-Zhu ;
Guo, Rong ;
Zhao, Cong ;
Xu, Jing ;
Song, Hang ;
Yu, Hua ;
Pilarsky, Christian ;
Nainu, Firzan ;
Li, Jing-Quan ;
Zhou, Xin-Ke ;
Zhang, Jian-Ye .
FRONTIERS IN PHARMACOLOGY, 2022, 13